Condition: Acute Kidney Injury · Chronic Kidney Diseases · Tomography, Optical Coherence · Sponsor: Centre Hospitalier William Morey - Chalon sur Saône
Kidney biopsy play a key role for the investigation of either acute kidney injury or chronic kidney disease. Despite possible complications due to the invasive nature of the biopsy, such procedure is still essential in a number of clinical situations to improve the diagnosis specificity of kidney disease, better inform about its prognosis and guide the management of a future treatment. Pursuing the idea to improve both performance and rapidity associated with the histopathological analysis of kidney biopsy, with a possible recourse to artificial intelligence-based renal pathology, the present study intends to assess the impact of direct histopathological examination of kidney biopsy with dynamic full-field optical coherence tomography in routine practices for the diagnosis of either acute kidney injury or chronic kidney disease.
This description comes directly from the study's public registry record.
Thomas Maldiney · +33 3 85 91 01 11 · thomas.maldiney@ch-chalon71.fr
Quentin Bernard · quentin.bernard@ch-chalon71.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier William Morey - Chalon sur Saône | Chalon-sur-Saône, Saône-et-Loire, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05728216